Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Arachidonic Acid and Phenytoin

Research Papers that Mention the Interaction

Furthermore, recent evidence suggests that phenytoin disrupts craniofacial and neural tube morphogenesis by inhibiting the arachidonic acid cascade , a pathogenesis already implicated for glucocorticoids and hyperglycemia in the palate.
This study tested the hypothesis that phenytoin interferes with the arachidonic acid cascade via the same biochemical pathway demonstrated for glucocorticoids.
Teratogenesis, carcinogenesis, and mutagenesis  •  1990  |  View Paper
Phenytoin significantly attenuated the accumulation of lactate and free fatty acids ( arachidonic acid and stearic acid) during ischemia and accelerated their recovery during recirculation.
Stroke  •  1990  |  View Paper
Specimens cultured in DPH plus AA had significantly fewer defects in each of the three features than those treated with DPH alone.
These data support the hypothesis that phenytoin disrupts normal embryonic development through interruption of the arachidonic acid cascade.
We hypothesize that phenytoin disrupts craniofacial morphogenesis by inhibiting the arachidonic acid cascade ; a pathogenesis already demonstrated for glucocorticoids and hyperglycemia.
Journal of craniofacial genetics and developmental biology  •  1988  |  View Paper
In this paper, we have investigated whether glucocorticoids and phenytoin inhibit arachidonic acid release and prostaglandin biosynthesis directly in the embryonic palates and whether the H-2 gene complex influences the degree of inhibition.
Journal of craniofacial genetics and developmental biology  •  1985  |  View Paper